Disinfecting Operating Rooms, Keeping Patients Safe

Featured in an OR Today webinar, learn how Phelps Memorial uses Tru-D in the OR.

LISTEN NOW
Surgeon

Tru-D in the OR

Surgical site infections (SSIs) are infections that occur after surgery in the part of the body where the surgery took place. In 2014, a total of 14.2 million operative procedures were performed in the inpatient setting in U.S. hospitals. A recent prevalence study found that SSIs were the most common healthcare-associated infection (HAI), accounting for 31 percent of all HAIs among hospitalized patients. The CDC HAI prevalence survey found that there were an estimated 157,500 surgical site infections associated with inpatient surgeries in 2011. Further, SSIs are the costliest HAI type with an estimated annual cost of $3.3 billion and are associated with nearly 1 million additional inpatient days annually.*

Hybrid-OR-Operating-Room-Philips-FD20-Ceiling-Skytron-LED-Surgical-Lights-Dual-Cockpit-RCH-1

The Role of the Environment

Over the past decade, researchers have concluded that manual disinfection is inadequate for terminal room disinfection.  According to studies, more than 50 percent of health care surfaces are not properly disinfected, leaving behind pathogens that increase the risk of infection by 39 – 353 percent for the next patient who enters the room.  In fact, according to a study by Jefferson, et al, on average, only 25 percent of targeted surfaces in 71 operating rooms had been properly cleaned.

AORN-logo-hg

According to AORN guidelines, enhanced environmental cleaning procedures, which are intended to decrease environmental contaminates on high-touch surfaces, should be implemented for cleaning following the care of patients who are infected or colonized with MDROs, including MRSA,  VRE, Vancomycin-intermediate Enterococcus, Vancomycin-resistant Staphylococcus aureus,  Vancomycin-intermediate Staphylococcus aureus, Carbapenem-resistant enterobacteriacae, Multidrug-resistant Acinetobacter spp, Extended spectrum beta-lactamase-producing organisms, and Klebsiella pneumoniae carbapenemase-producing organisms

Tru-D_2018-Device_noBkg

Tested. Trusted.

In a recent study published in the American Journal of Infection Control, Tru-D was shown to reduce bioburden on anesthesia workstations. In the study, UVC disinfection greatly influenced bioburden reduction regardless of room size and exposure type. All trials, compared with the controls, exhibited a bioburden reduction of more than 99 percent. The research team went on to suggest that Tru-D’s technology is an important supplement to the manual cleaning process. Individual hospital results may vary based on adherence to standard disinfection protocol.

Incorporating enhanced terminal room disinfection into your infection prevention protocols in the OR is an important addition to handwashing, manual cleaning and antibiotic stewardship.

To learn more about Tru-D’s technology in OR Today, click here.